Literature DB >> 19150188

Application of multi-factorial design of experiments to successfully optimize immunoassays for robust measurements of therapeutic proteins.

Chad A Ray1, Vimal Patel, Judy Shih, Chris Macaraeg, Yuling Wu, Theingi Thway, Mark Ma, Jean W Lee, Binodh Desilva.   

Abstract

Developing a process that generates robust immunoassays that can be used to support studies with tight timelines is a common challenge for bioanalytical laboratories. Design of experiments (DOEs) is a tool that has been used by many industries for the purpose of optimizing processes. The approach is capable of identifying critical factors and their interactions with a minimal number of experiments. The challenge for implementing this tool in the bioanalytical laboratory is to develop a user-friendly approach that scientists can understand and apply. We have successfully addressed these challenges by eliminating the screening design, introducing automation, and applying a simple mathematical approach for the output parameter. A modified central composite design (CCD) was applied to three ligand binding assays. The intra-plate factors selected were coating, detection antibody concentration, and streptavidin-HRP concentrations. The inter-plate factors included incubation times for each step. The objective was to maximize the logS/B (S/B) of the low standard to the blank. The maximum desirable conditions were determined using JMP 7.0. To verify the validity of the predictions, the logS/B prediction was compared against the observed logS/B during pre-study validation experiments. The three assays were optimized using the multi-factorial DOE. The total error for all three methods was less than 20% which indicated method robustness. DOE identified interactions in one of the methods. The model predictions for logS/B were within 25% of the observed pre-study validation values for all methods tested. The comparison between the CCD and hybrid screening design yielded comparable parameter estimates. The user-friendly design enables effective application of multi-factorial DOE to optimize ligand binding assays for therapeutic proteins. The approach allows for identification of interactions between factors, consistency in optimal parameter determination, and reduced method development time.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19150188     DOI: 10.1016/j.jpba.2008.11.039

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  4 in total

1.  Ligand binding assays in the 21st Century laboratory: automation.

Authors:  Ago B Ahene; Chris Morrow; David Rusnak; Susan Spitz; Joel Usansky; Holger Pils; Francesca Civoli; Kinnari Pandya; Brian Sue; Daniel Leach; John Derent
Journal:  AAPS J       Date:  2012-03       Impact factor: 4.009

Review 2.  Design of Experiments As a Tool for Optimization in Recombinant Protein Biotechnology: From Constructs to Crystals.

Authors:  Christos Papaneophytou
Journal:  Mol Biotechnol       Date:  2019-12       Impact factor: 2.695

Review 3.  Antibody-based protein multiplex platforms: technical and operational challenges.

Authors:  Allison A Ellington; Iftikhar J Kullo; Kent R Bailey; George G Klee
Journal:  Clin Chem       Date:  2009-12-03       Impact factor: 8.327

Review 4.  Analytical Tools to Improve Optimization Procedures for Lateral Flow Assays.

Authors:  Helen V Hsieh; Jeffrey L Dantzler; Bernhard H Weigl
Journal:  Diagnostics (Basel)       Date:  2017-05-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.